US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about DOI and DOC
Recent news which mentions DOI and DOC
DEA's Case For Scheduling Psychedelics Challenged In Landmark Hearing
November 20, 2024
Tickers
NEWS
Tags
Federal Schedule I
Controlled Substance Act
Drug Enforcement Administration
From
Benzinga
Psychedelic Drug DOI Pinpoints Anxiety Circuits Avoiding Hallucinogenic Effects, Study Finds
October 28, 2024
Tickers
NEWS
Tags
Psychedelics
anxiety
Market News
From
Benzinga
DEA Faces Setback As Judge Denies Request To Block Witnesses In Psychedelics Ban Hearing
October 23, 2024
Tickers
NEWS
Tags
Students for Sensible Drug Policy
Panacea Plant Sciences
Drug Enforcement Administration
From
Benzinga